Alsugair, A., Fathima, S., Aperna, F., Gangat, N. and Tefferi, A. (2020) “Sodium-glucose co-transporter-2 inhibitor treatment-associated changes in hemoglobin level in anemic patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2024.287032.